Log In
Print this Print this

Biosimilar cetuximab (STI-001)

  Manage Alerts
Collapse Summary General Information
Company Mabtech Ltd.
DescriptionBiosimilar of cetuximab, a chimeric mAb targeting EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionBinds epidermal growth factor (EGF) receptor; Antibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase III
Standard IndicationColorectal cancer
Indication DetailsTreat EGFR-expressing metastatic colorectal carcinoma
Regulatory Designation
PartnerSorrento Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today